Europe Imaging CRO Market Size, Share, By Services Offered (Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, and Others), By Imaging Modality (Magnetic Resonance Imaging, Computed Tomography Scan, Positron Emission Tomography, and Others), By Application (Oncology, Cardiovascular, Neurology, Ophthalmology, and Others), By End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Medical Device Manufacturers, and Others) and By Country (UK, Germany, France, Russia, Italy and Rest of Europe) - Trends, Analysis and Forecast till 2034

Report Code: PMI529524 | Publish Date: June 2024 | No. of Pages: 128

Europe Imaging Cro Market Overview

Europe Imaging CRO Market Size was valued at USD 1.78 Billion in 2024 and is projected to grow at a CAGR of 7.1% to reach USD 3.52 Billion by 2034.

The European Imaging Contract Research Organization (CRO) market encompasses specialized service providers that support pharmaceutical, biotechnology, and medical device companies in imaging-related research activities. These services are crucial during the preclinical and clinical phases, offering advanced imaging analysis and data management to enhance the understanding of drug mechanisms and therapeutic efficacy. The market is growing due to the increasing complexity of clinical trials and the demand for sophisticated imaging technologies to improve diagnostic and therapeutic outcomes.

Europe Imaging Cro Market Dynamics

Key Drivers of Target Market:

Innovative Imaging Technologies

Europe is recognized for its leadership in medical innovation. The development and widespread adoption of advanced imaging technologies, such as high-resolution MRI, CT scans, and PET scans, have significantly improved the capability to visualize and assess drug efficacy and disease progression. These technologies provide detailed and precise data essential for the successful development of new therapeutics. The robust research infrastructure and significant investments in healthcare technology further drive these advancements.

Rising Trend of Outsourcing R&D

There is a growing tendency among pharmaceutical and biotechnology companies in Europe to outsource their imaging needs to CROs. This trend is driven by the high costs and specialized expertise required for advanced imaging studies. Outsourcing allows companies to access cutting-edge imaging technologies and skilled professionals without the substantial investment to maintain these capabilities in-house. This strategy helps streamline R&D activities, enabling companies to focus on their core competencies while leveraging the expertise and technology of CROs.

Restrains:

Complex Regulatory Environment

The European imaging CRO market faces significant challenges due to stringent regulatory requirements set by bodies such as the European Medicines Agency (EMA). These regulations are designed to ensure the safety and accuracy of imaging procedures used in clinical trials. Compliance with these regulations can be costly and time-consuming, posing a considerable challenge for CROs. Non-compliance can result in severe penalties, complicating the operational landscape for these organizations. The stringent regulatory environment can slow the development and approval processes for new drugs and medical devices, creating a substantial hurdle for the imaging CRO market.

Europe Imaging Cro Market Segmentation

The market is segmented based on Services Offered, Imaging Modality, Application, End-Users and country.

Europe Imaging CRO Market Report Scope:

Attribute

Details

Market Size 2024

USD 1.78 Billion

Projected Market Size 2034

USD 3.52 Billion

CAGR Growth Rate

7.1%

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Services Offered - Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, and Others

By Imaging Modality - Magnetic Resonance Imaging, Computed Tomography Scan, Positron Emission Tomography, and Others

By Application - Oncology, Cardiovascular, Neurology, Ophthalmology, and Others

By End User - Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Medical Device Manufacturers, and Others

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2023 to 2034. For the purpose of this study, has segmented the Imaging CRO Market report based on Services Offered, Imaging Modality, Application, End User and Country:

Segmentation:

By Services Offered:

  • Image Collection & Quality Control
  •  Imaging Acquisition & Protocol Development
  •  Digital Image Conversion
  • Application Design
  • Support & Maintenance
  • Others

By Imaging Modality:

  • Magnetic Resonance Imaging
  • Computed Tomography Scan
  • Positron Emission Tomography
  • Others

By Application:

  • Oncology
  • Cardiovascular
  • Neurology
  • Ophthalmology
  • Others

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Medical Device Manufacturers
  • Others

By Country:

  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe

Europe Imaging Cro Market Key Players

The key players operating the Imaging CRO Market includes IQVIA, PAREXEL, PRA HEALTH SCIENCES, ICON, Syneos Health, Labcorp Drug Development, PPD, Fisher Clinical Services. 

Europe Imaging Cro Market Company Profile

  • IQVIA, Inc. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PAREXEL
  • PRA HEALTH SCIENCES  
  • ICON
  • Syneos Health, Ltd.
  • Labcorp Drug Development  
  • PPD, INC.
  • Fisher Clinical Services    

"*" marked represents similar segmentation in other categories in the respective section.

Europe Imaging Cro Market Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Services Offered
      • Market Snippet, By Imaging Modality
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Country
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Product Launch
    • Merger and Acquisitions
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis

Market Segmentation, By Services Offered, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Image Collection & Quality Control
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Imaging Acquisition & Protocol Development
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Digital Image Conversion
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Application Design
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Support & Maintenance
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Imaging Modality, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Magnetic Resonance Imaging
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Computed Tomography Scan
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Positron Emission Tomography
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Application, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Oncology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cardiovascular
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Neurology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Ophthalmology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, End User, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Academic & Research Institutions
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Medical Device Manufacturers
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Country, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Country Trends
  • Europe
    • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • Germany
      • France
      • Russia
      • Italy
      • Rest of Europe

Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • IQVIA
    • PAREXEL
    • PRA HEALTH SCIENCES  
    • ICON
    • Syneos Health, Ltd.
    • Labcorp Drug Development  
    • PPD, Inc.
    • Fisher Clinical Services

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

The Europe Imaging CRO Market is segmented into Services Offered, Imaging Modality, Application, End User and Country.

Innovative imaging technologies and rising trend of outsourcing R&D.

The Europe Imaging CRO Market is segmented by country into the UK, Germany, France, Russia, Italy, and the Rest of Europe. Germany is expected to dominate the Market due to its large number of Investments.

The key players operating the Imaging CRO Market includes, IQVIA, PAREXEL, PRA HEALTH SCIENCES, ICON, Syneos Health, Ltd., Labcorp Drug Development, PPD, INC., Fisher Clinical Services.